REGENERX BIOPHARMACEUTICALS INC Quarterly Interest Expense in USD from Q1 2012 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q1 2012 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Interest Expense for the quarter ending March 31, 2023 was $80.3K, unchanged year-over-year.
  • Regenerx Biopharmaceuticals Inc Interest Expense for the twelve months ending March 31, 2023 was $326K, a 0.24% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2022 was $326K, a 0.24% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2021 was $325K, a 39.7% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2020 was $233K, a 51.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $326K $80.3K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $326K $82.1K +$1.00 +0% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-11
Q3 2022 $326K $82.1K +$769 +0.95% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $325K $81.2K -$1 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $325K $80.3K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $325K $82.1K +$4.87K +6.31% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-11
Q3 2021 $320K $81.3K +$29.1K +55.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $291K $81.2K +$29.6K +57.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $261K $80.3K +$28.7K +55.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $233K $77.2K +$25K +47.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $208K $52.2K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $208K $51.6K +$12.2K +30.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $195K $51.6K +$42K +438% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $153K $52.2K +$48.2K +1202% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 $105K $52.2K +$33.5K +179% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $71.7K $39.4K +$13.7K +53.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $58K $9.59K -$29.2K -75.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $87.3K $4.01K -$37.6K -90.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 $125K $18.7K -$24.9K -57.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $150K $25.8K -$17.3K -40.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $167K $38.8K -$3.8K -8.92% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $171K $41.6K -$2K -4.59% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 $173K $43.6K -$1 0% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $173K $43.1K -$1 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $173K $42.6K -$472 -1.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $173K $43.6K -$1 0% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 $173K $43.6K +$1.00 +0% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $173K $43.1K $0 0% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 $173K $43.1K +$472 +1.11% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $173K $43.6K -$720 -1.63% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 $174K $43.6K -$3.42K -7.27% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $177K $43.1K -$3.38K -7.27% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q1 2015 $180K $42.6K -$3.08K -6.73% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 $183K $44.3K +$772 +1.77% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-11
Q3 2014 $183K $47K +$17.8K +61.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $165K $46.5K +$25.3K +119% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $140K $45.7K +$38.7K +549% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $101K $43.5K +$37.8K +664% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $63.1K $29.2K +$29.2K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $33.9K $21.2K +$21.2K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $12.7K $7.04K +$7.04K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $5.7K $5.7K Oct 1, 2012 Dec 31, 2012 10-K 2014-04-04
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.